Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response

Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response

US Patent 11660356 · Granted May 30, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiolabelled antibody fragments for use in treating cancer2025
Radiolabelled antibody fragments for use in treating cancer2025
Human PD-L1-binding immunoglobulins2024
Human PD-L1-binding immunoglobulins2024
Radiolabelled antibody fragments for use in treating cancer2022
Radiolabelled antibody fragments for use in treating cancer2022
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta2022
Targeting and in vivo imaging of tumor-associated macrophages2018
Targeting and in vivo imaging of tumor-associated macrophages2018
Radio-labelled antibody fragments for use in the prevention and/or treatment of 2018
Radio-labelled antibody fragments for use in the prevention and/or treatment of 2018
Anti-VCAM-1 nanobodies2017